Medications to Avoid While Taking Lithium
Avoid NSAIDs, thiazide diuretics, and ACE inhibitors/ARBs while on lithium, as these significantly increase the risk of lithium toxicity by reducing renal clearance and elevating serum lithium levels. 1, 2
High-Risk Drug Classes Requiring Avoidance or Extreme Caution
NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)
- These are among the most dangerous interactions with lithium 3, 1, 4
- NSAIDs reduce renal lithium clearance, causing potentially toxic accumulation
- Antibiotics also contribute substantially to elevated lithium levels 3
- Even short courses can precipitate toxicity
Diuretics
- Thiazide diuretics pose the highest risk and should be avoided 5, 1, 6
- They alter sodium balance, which directly affects lithium retention
- Can trigger self-perpetuating lithium intoxication 5
- Loop diuretics carry lower but still significant risk
- The combination of diuretics with ACE inhibitors creates particularly dangerous synergy 7
ACE Inhibitors and Angiotensin Receptor Blockers (ARBs)
- Increase lithium levels by reducing renal clearance 1, 6, 2
- However, recent evidence suggests these may be used cautiously if: 7
- Thiazide diuretics are NOT co-administered
- Patient maintains adequate hydration
- Lithium levels are monitored more frequently (every 8-10 weeks minimum)
- Female patients and older adults face higher toxicity risk with this combination 6
Moderate-Risk Medications Requiring Close Monitoring
Other Drug Interactions
- Theophylline: Can alter lithium levels 3
- Neuromuscular blocking agents: Potential interaction during anesthesia 5
- Phenytoin and carbamazepine: Weak evidence but warrant caution 5
- Methyldopa and iodide salts: Limited data but consider temporary lithium withdrawal if used 5
Critical Clinical Pitfalls
The Dehydration Factor
- Dehydration is a necessary cofactor for many lithium toxicity cases 7, 4
- Even "safe" drug combinations become dangerous when patients are dehydrated
- Patient education about maintaining hydration is essential 4
Age and Renal Function
- Older adults require lower therapeutic targets (0.4-0.6 mmol/L) and more frequent monitoring 8, 9
- If GFR <45 ml/min/1.73m², do not initiate lithium 9
- If GFR <30 ml/min/1.73m², consult nephrology and strongly consider discontinuation 9
Monitoring Requirements When Risk Medications Are Necessary
When potentially interacting medications cannot be avoided:
- Check lithium levels within 5-7 days of starting the interacting drug
- Increase monitoring frequency to every 8-10 weeks (or more frequently in elderly) 8, 9
- Reduce lithium dose preemptively by 25-50% when starting high-risk medications
- Monitor for early toxicity signs: tremor, confusion, polyuria, nausea 4
The Preventability Problem
64.8% of lithium toxicity cases are preventable, most commonly due to: 4
- Delayed monitoring (55.9% of preventable cases)
- Dehydration (39.0%)
- Drug interactions (17.0%)
- Previous high lithium episodes within 3 years (13.6%)
Practical Algorithm for Drug Interactions
When a potentially interacting medication is being considered:
Absolute contraindications (avoid completely):
- Thiazide diuretics + lithium
- NSAIDs for chronic use (short courses require intensive monitoring)
- Any new medication when patient is dehydrated
Relative contraindications (use only if benefits clearly outweigh risks):
- ACE inhibitors/ARBs (acceptable if no thiazides, good hydration, frequent monitoring)
- Loop diuretics (less risky than thiazides but still problematic)
Before starting any interacting medication:
- Ensure current lithium level is at lower end of therapeutic range
- Verify adequate renal function
- Consider prophylactic lithium dose reduction
- Schedule lithium level check within 5-7 days
If interaction cannot be avoided:
- Increase monitoring frequency
- Educate patient about toxicity symptoms
- Ensure adequate hydration status
- Consider temporary lithium withdrawal if short-term alternative exists 5